Skip to content

Drug interactions

Irinotecan liposomal + Nicardipine

Severity: Minor

Irinotecan liposomal and Nicardipine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nicardipine inhibits P-glycoprotein in vitro, which could theoretically raise irinotecan or SN-38 exposure. Clinically meaningful effects with the liposomal formulation are not established, and the liposomal carrier alters its disposition.

What this interaction means in plain words

Irinotecan liposomal and Nicardipine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Possible P-glycoprotein inhibition by nicardipine; the clinical relevance for liposomal irinotecan is not established.

What to do

No dose change is needed. Monitor for diarrhea and neutropenia as part of routine irinotecan care.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Irinotecan liposomal and Nicardipine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Irinotecan liposomal with Nicardipine?

MediHelp rates the interaction as minor. Irinotecan liposomal and Nicardipine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Nicardipine inhibits P-glycoprotein in vitro, which could theoretically raise irinotecan or SN-38 exposure. Clinically meaningful effects with the liposomal formulation are not established, and the liposomal carrier alters its disposition.

How serious is the interaction between Irinotecan liposomal and Nicardipine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed. Monitor for diarrhea and neutropenia as part of routine irinotecan care.

What other medicines interact with Nicardipine?

MediHelp also lists interactions of Nicardipine with, for example, Amifostine, Amlodipine-olmesartan-hydrochlorothiazide, Betrixaban. The full list is on the Nicardipine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in